What is the appropriate management for a 33-year-old patient with chronic microcytic anemia, hemoglobin 8.9 g/dL, hematocrit 30.8 %, mean corpuscular volume 69.5 fL, mean corpuscular hemoglobin 20.1 pg, mean corpuscular hemoglobin concentration 28.9 g/dL, red cell distribution width 16.5 %, and platelet count 239 ×10⁹/L?

Diagnostic Workup and Management of Chronic Microcytic Anemia

This patient requires immediate serum ferritin testing to differentiate iron deficiency anemia from other causes of microcytic anemia, followed by iron supplementation if ferritin is low (<45 mg/dL), or additional testing including transferrin saturation, hemoglobin electrophoresis, and consideration of genetic disorders if ferritin is normal or elevated.

Initial Diagnostic Approach

The laboratory values reveal severe microcytic anemia (MCV 69.5 fL, well below 80 fL) with marked hypochromia (MCH 20.1 pg, MCHC 28.9 g/dL) and elevated RDW (16.5%), indicating heterogeneous red cell populations. With hemoglobin at 8.9 g/dL, this patient is significantly anemic and requires both diagnosis and treatment 1.

First-Line Testing: Serum Ferritin

Measure serum ferritin immediately as the single most important initial test 2, 1. The interpretation depends on the result:

• If ferritin <45 mg/dL: Diagnose iron deficiency anemia and proceed to identify the source of iron loss 2
• If ferritin 45-100 mg/dL with inflammatory conditions: Consider confirmatory testing with transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin equivalent 2
• If ferritin >100 mg/dL or normal with low transferrin saturation: Pursue alternative diagnoses 1

Differential Diagnosis Based on Testing

If Iron Deficiency is Confirmed

In a 33-year-old with chronic anemia, investigate:

• Gastrointestinal blood loss (most common in adults; consider GI malignancy) 1
• Menstrual blood loss (if female) 2
• Dietary insufficiency 2
• Malabsorption (celiac disease, H. pylori infection) 2

If Iron Studies Are Inconclusive

Proceed with:

• Total iron-binding capacity and transferrin saturation 1
• Hemoglobin electrophoresis to evaluate for thalassemia trait (expect elevated HbA2 >3.5% in beta-thalassemia trait) 1
• Consider genetic testing for TMPRSS6 mutations if patient has low transferrin saturation, normal/low ferritin, and poor response to oral iron with partial response to IV iron (suggests iron-refractory iron deficiency anemia) 3

Treatment Algorithm

For Confirmed Iron Deficiency Anemia

Start with oral iron supplementation 2:

• Ferrous sulfate, ferrous fumarate, or ferrous gluconate (least expensive options)
• Take on empty stomach when possible, or with meals if better tolerated
• Add 500 mg vitamin C to enhance absorption 2
• Taking with meat protein improves absorption 2

If oral iron fails or is not tolerated, switch to IV iron 3, 2:

• Calculate total iron deficit based on hemoglobin deficit and need to rebuild stores 3
• Administer doses every 3-7 days until total dose completed 3
• Monitor ferritin levels; keep <500 mg/L to avoid toxicity, especially in younger patients 3

For Iron-Refractory Iron Deficiency Anemia (IRIDA)

If TMPRSS6 mutation confirmed 3:

1. Trial oral iron with ascorbic acid first
2. If inadequate response, proceed directly to IV iron supplementation
3. Monitor serum hepcidin (elevated hepcidin:transferrin saturation ratio suggests IRIDA)

Critical Pitfalls to Avoid

• Do not start iron therapy without confirming iron deficiency, especially if total iron-binding capacity is low, as this suggests anemia of chronic disease where iron supplementation may be harmful 4
• Do not assume thalassemia trait based solely on MCV; HbA2 must be elevated (>3.5%) for beta-thalassemia trait diagnosis 1
• Do not overlook GI malignancy in adults with new-onset iron deficiency anemia; endoscopic evaluation is essential 2
• With hemoglobin 8.9 g/dL, this patient is approaching the threshold where oxygen delivery may be compromised (critical level ~7-8 g/dL), particularly with physical activity or underlying cardiopulmonary disease 5

When to Consider Rare Genetic Disorders

The "long history of anemia" raises concern for inherited conditions 6. Consider genetic evaluation if:

• Normal or elevated ferritin with low transferrin saturation
• Poor response to adequate iron replacement
• Family history of microcytic anemia
• Elevated serum hepcidin despite iron deficiency 3

Genetic microcytic anemias include defects in intestinal iron absorption, transferrin receptor cycle disorders, mitochondrial iron utilization defects, and iron recycling abnormalities 6.